Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography/computed tomography.

Garcia A, Venugopal A, Pan ML, Mukherjee J.

Diabetes Technol Ther. 2014 Oct;16(10):640-3. doi: 10.1089/dia.2014.0041. Epub 2014 May 14.

2.

18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies.

Garcia A, Mirbolooki MR, Constantinescu C, Pan ML, Sevrioukov E, Milne N, Wang PH, Lakey J, Chandy KG, Mukherjee J.

J Nucl Med. 2011 Jul;52(7):1125-32. doi: 10.2967/jnumed.111.088583. Epub 2011 Jun 16.

3.

¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors.

Pandey S, Venugopal A, Kant R, Coleman R, Mukherjee J.

Nucl Med Biol. 2014 May-Jun;41(5):426-31. doi: 10.1016/j.nucmedbio.2014.01.011. Epub 2014 Jan 31.

4.

Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes.

Singhal T, Ding YS, Weinzimmer D, Normandin MD, Labaree D, Ropchan J, Nabulsi N, Lin SF, Skaddan MB, Soeller WC, Huang Y, Carson RE, Treadway JL, Cline GW.

Mol Imaging Biol. 2011 Oct;13(5):973-84. doi: 10.1007/s11307-010-0406-x. Epub 2010 Sep 8.

5.

Impact of isoflurane anesthesia on D2 receptor occupancy by [18F]fallypride measured by microPET with a modified Logan plot.

Tantawy MN, Peterson TE, Jones CK, Johnson K, Rook JM, Conn PJ, Baldwin RM, Ansari MS, Kessler RM.

Synapse. 2011 Nov;65(11):1173-80. doi: 10.1002/syn.20955. Epub 2011 Jun 17.

7.

Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.

Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J.

Nucl Med Biol. 2014 Nov-Dec;41(10):841-7. doi: 10.1016/j.nucmedbio.2014.08.002. Epub 2014 Aug 8.

8.

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.

Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.

Nucl Med Biol. 1999 Jul;26(5):519-27.

PMID:
10473190
9.

Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.

Constantinescu CC, Coleman RA, Pan ML, Mukherjee J.

Synapse. 2011 Aug;65(8):778-87. doi: 10.1002/syn.20904. Epub 2011 Mar 21.

10.
12.

[(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.

Tantawy MN, Jones CK, Baldwin RM, Ansari MS, Conn PJ, Kessler RM, Peterson TE.

Nucl Med Biol. 2009 Nov;36(8):931-40. doi: 10.1016/j.nucmedbio.2009.06.007. Epub 2009 Oct 3.

13.

Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride.

Choi JY, Kim CH, Jeon TJ, Cho WG, Lee JS, Lee SJ, Choi TH, Kim BS, Yi CH, Seo Y, Yi DI, Han SJ, Lee M, Kim DG, Lee JD, An G, Ryu YH.

Appl Radiat Isot. 2012 Dec;70(12):2689-94. doi: 10.1016/j.apradiso.2012.08.005. Epub 2012 Aug 19.

PMID:
23041777
14.

Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.

Wang Y, Lim K, Normandin M, Zhao X, Cline GW, Ding YS.

Nucl Med Biol. 2012 Feb;39(2):167-76. doi: 10.1016/j.nucmedbio.2011.07.011. Epub 2011 Oct 26.

15.
16.

Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.

Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P.

Epilepsia. 2006 Aug;47(8):1392-6.

17.

Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.

Matschinsky FM, Pagliara AS, Stillings SN, Hover BA.

J Clin Invest. 1976 Nov;58(5):1193-200.

18.

Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).

Wängler B, Schneider S, Thews O, Schirrmacher E, Comagic S, Feilen P, Schwanstecher C, Schwanstecher M, Shiue CY, Alavi A, Höhnemann S, Piel M, Rösch F, Schirrmacher R.

Nucl Med Biol. 2004 Jul;31(5):639-47.

PMID:
15219283
19.

Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.

Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Rösch F, Vernaleken I, Schäfer WM, Gründer G.

Biol Psychiatry. 2011 Oct 15;70(8):770-6. doi: 10.1016/j.biopsych.2011.05.035. Epub 2011 Jul 29.

PMID:
21802658
20.

Decreased [3H] YM-09151-2 binding to dopamine D2 receptors in the hypothalamus, brainstem and pancreatic islets of streptozotocin-induced diabetic rats.

Shankar PN, Joseph A, Paulose CS.

Eur J Pharmacol. 2007 Feb 28;557(2-3):99-105. Epub 2006 Nov 15.

PMID:
17174299

Supplemental Content

Support Center